May 20, 2020
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction
May 20, 2020
China Biologic Reports Financial Results for the First Quarter of 2020
Nov 13, 2019
China Biologic Reports Financial Results for the Third Quarter of 2019
Oct 17, 2019
China Biologic Special Committee Retains Financial Advisor and Legal Counsel
Sep 24, 2019
China Biologic Forms Special Committee to Review "Going Private" Proposal
Sep 18, 2019
China Biologic Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
Aug 05, 2019
China Biologic Reports Financial Results for the Second Quarter of 2019
May 10, 2019
China Biologic Reports Financial Results for the First Quarter of 2019
Mar 06, 2019
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018
Jan 07, 2019
China Biologic Reiterates Full Year 2018 Financial Forecast
Dec 14, 2018
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman
Aug 28, 2018
China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman
Aug 13, 2018
China Biologic Names Bing Li as New CEO
Jun 19, 2018
China Biologic Announces Receipt of Non-Binding Acquisition Proposal
Jun 11, 2018
China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant
May 04, 2018
China Biologic Reports Financial Results for the First Quarter of 2018
Apr 24, 2018
China Biologic to Report First Quarter of 2018 Financial Results
Feb 23, 2018
China Biologic Products to Report Fourth Quarter and Fiscal Year 2017 Financial Results
Feb 14, 2018
China Biologic to Build New Collection Station in Hainan Province
Jan 08, 2018
China Biologic Announces Corporate Update